Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients

BACKGROUND: There has been significant controversy regarding the effects of pre‐hospitalization use of renin‐angiotensin system (RAS) inhibitors on the prognosis of hypertensive COVID‐19 patients. METHODS AND RESULTS: We retrospectively assessed 2,297 hospitalized COVID‐19 patients at Tongji Hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Wang, Feng, Chen, Peng, Jiang, Jiangang, Cui, Guanglin, Zhou, Ning, Moroni, Francesco, Moslehi, Javid J., Ammirati, Enrico, Wang, Dao Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763411/
https://www.ncbi.nlm.nih.gov/pubmed/32807002
http://dx.doi.org/10.1161/JAHA.120.017736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763411/
https://www.ncbi.nlm.nih.gov/pubmed/32807002
http://dx.doi.org/10.1161/JAHA.120.017736

Ejemplares similares